Skip to search formSkip to main contentSkip to account menu

naltalimide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Re: Mechanisms of Inhibitory Action of TRK-130 (Naltalimide), a μ-Opioid Receptor Partial Agonist, on the Micturition Reflex.
  • A. Wein
  • Journal of Urology
  • 2019
  • Corpus ID: 58589895
available at http://www.ncbi.nlm.nih.gov/pubmed/28093646 Editorial Comment: The overall conclusion here is that TRK-130, a m… 
2017
2017
Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex
PurposeTo clarify the mechanism of inhibitory action of TRK-130 (Naltalimide), a unique µ-opioid receptor partial agonist, on the… 
2016
2016
Re: Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder.
  • A. Wein
  • Journal of Urology
  • 2016
  • Corpus ID: 808804
2015
2015
Re: Characteristics of TRK-130 (naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder.
  • A. Atala
  • Journal of Urology
  • 2015
  • Corpus ID: 41727740
2014
2014
Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
We characterized TRK-130 (N-[(5R,6R,14S)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]phthalimide; naltalimide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)